CORT vs. CRS
CORT (Corcept Therapeutics Incorporated) and CRS (Carpenter Technology Corporation) are both stocks. CORT operates in Biotechnology (Healthcare), while CRS operates in Metal Fabrication (Industrials). Over the past 10 years, CORT returned 31.68%/yr vs 35.01%/yr for CRS. At a 0.21 correlation, their price movements are largely independent.
Performance
CORT vs. CRS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CORT achieves a 138.25% return, which is significantly higher than CRS's 78.53% return. Over the past 10 years, CORT has underperformed CRS with an annualized return of 31.68%, while CRS has yielded a comparatively higher 35.01% annualized return.
CORT
- 1D
- -0.41%
- 1M
- 47.08%
- YTD
- 138.25%
- 6M
- -5.77%
- 1Y
- 18.34%
- 3Y*
- 52.65%
- 5Y*
- 30.95%
- 10Y*
- 31.68%
CRS
- 1D
- -0.17%
- 1M
- 37.31%
- YTD
- 78.53%
- 6M
- 74.76%
- 1Y
- 126.36%
- 3Y*
- 121.69%
- 5Y*
- 68.28%
- 10Y*
- 35.01%
CORT vs. CRS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 138.25% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
CRS Carpenter Technology Corporation | 78.53% | 86.23% | 141.72% | 94.48% | 29.50% | 2.66% | -39.44% | 42.12% | -29.16% | 43.40% |
Correlation
The correlation between CORT and CRS is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004 | 0.21 |
Fundamentals
CORT:
$8.66B
CRS:
$28.24B
CORT:
$0.41
CRS:
$9.51
CORT:
202.17
CRS:
59.07
CORT:
100.71
CRS:
0.05
CORT:
12.51
CRS:
9.34
CORT:
13.57
CRS:
13.66
CORT:
$769.10M
CRS:
$3.03B
CORT:
$755.64M
CRS:
$900.50M
CORT:
$3.66M
CRS:
$745.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CORT vs. CRS — Risk / Return Rank
CORT
CRS
CORT vs. CRS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Carpenter Technology Corporation (CRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CORT | CRS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.42 | ||
| Sortino ratioReturn per unit of downside risk | -2.56 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.44 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.26 | 6.68 | -6.42 |
| Martin ratioReturn relative to average drawdown | 0.47 | 15.72 | -15.25 |
Loading charts...
Drawdowns
CORT vs. CRS - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.29%, which is greater than CRS's maximum drawdown of -84.68%. Use the drawdown chart below to compare losses from any high point for CORT and CRS.
Loading charts...
Drawdown Indicators
| CORT | CRS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.29% | -84.68% | -9.61% |
Max Drawdown (1Y)Largest decline over 1 year | -64.40% | -19.08% | -45.32% |
Max Drawdown (3Y)Largest decline over 3 years | -71.85% | -28.74% | -43.11% |
Max Drawdown (5Y)Largest decline over 5 years | -71.85% | -41.86% | -29.99% |
Max Drawdown (10Y)Largest decline over 10 years | -71.85% | -74.70% | +2.85% |
Current DrawdownCurrent decline from peak | -27.41% | -0.17% | -27.24% |
Average DrawdownAverage peak-to-trough decline | -53.45% | -27.23% | -26.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.37% | 8.09% | +27.28% |
Volatility
CORT vs. CRS - Volatility Comparison
Corcept Therapeutics Incorporated (CORT) has a higher volatility of 14.28% compared to Carpenter Technology Corporation (CRS) at 12.83%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than CRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CORT | CRS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.28% | 12.83% | +1.45% |
Volatility (6M)Calculated over the trailing 6-month period | 85.36% | 33.92% | +51.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 76.98% | 48.29% | +28.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.58% | 46.70% | +27.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.23% | 48.88% | +18.35% |
Dividends
CORT vs. CRS - Dividend Comparison
CORT has not paid dividends to shareholders, while CRS's dividend yield for the trailing twelve months is around 0.14%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CRS Carpenter Technology Corporation | 0.14% | 0.25% | 0.47% | 1.13% | 2.17% | 2.74% | 2.75% | 1.61% | 2.13% | 1.41% | 1.99% | 2.38% |
Financials
CORT vs. CRS - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Carpenter Technology Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. CRS - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
CRS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Carpenter Technology Corporation reported a gross profit of 251.80M and revenue of 811.50M. Therefore, the gross margin over that period was 31.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
CRS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Carpenter Technology Corporation reported an operating income of 186.50M and revenue of 811.50M, resulting in an operating margin of 23.0%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
CRS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Carpenter Technology Corporation reported a net income of 139.60M and revenue of 811.50M, resulting in a net margin of 17.2%.
Frequently Asked Questions
CORT and CRS have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CORT has higher volatility (14.28%) compared to CRS (12.83%). In terms of maximum drawdown, CORT dropped -94.29% vs CRS's -84.68%.
CRS currently has the higher Sharpe Ratio (2.64 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CORT and CRS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer